Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) Short Interest Down 16.5% in February

Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) was the recipient of a significant drop in short interest during the month of February. As of February 28th, there was short interest totalling 30,900 shares, a drop of 16.5% from the February 13th total of 37,000 shares. Based on an average daily volume of 13,200 shares, the days-to-cover ratio is presently 2.3 days.

Algernon Pharmaceuticals Stock Performance

Shares of OTCMKTS:AGNPF opened at $0.06 on Tuesday. Algernon Pharmaceuticals has a 52-week low of $0.04 and a 52-week high of $0.12. The business has a 50-day moving average price of $0.06 and a 200-day moving average price of $0.06.

Algernon Pharmaceuticals Company Profile

Algernon Pharmaceuticals Inc operates as a clinical stage pharmaceutical development company. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, pancreatic and small cell lung cancer, and acute lung injury in Canada and Australia.